Global Health peers

·Pharma & HealthChart ›

Companies like Global Healthlatest year

Global HealthMEDANTA · FY26 · this company
Market cap₹31,705
P/E56.98×
Sales growth+26.5%
ROE15.2%
Max Healthcare InstituteMAXHEALTH · FY26
Open ›
Market cap₹79,310
P/E54.96×
Sales growth+20.3%
ROE14.3%
Apollo Hospitals EnterpriseAPOLLOHOSP · FY26
Open ›
Market cap₹1,10,805
P/E57.06×
Sales growth+20.6%
ROE22.0%
Fortis HealthcareFORTIS · FY26
Open ›
Market cap₹53,678
P/E51.52×
Sales growth+17.5%
ROE11.1%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MEDANTA₹1,180.00

Global Health Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHAPOLLOHOSPFORTISGLAXOANTHEMAJANTPHARMIPCALABABBOTINDIAMcap ₹31,705 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
MEDANTA
FY26
MAXHEALTH
FY26
APOLLOHOSP
FY26
FORTIS
FY26
Peer
Average
Valuation — at last close
P/E56.98×54.96×57.06×◆ 51.52×54.51× +5%
P/B8.00×7.38×11.69×◆ 5.42×8.16× -2%
EV/EBITDA34.59×36.60×30.46×◆ 26.98×31.35× +10%
Market Cap₹31,705 Cr₹79,310 Cr₹1.11L Cr₹53,678 Cr₹81,264 Cr -61%
Growth
Revenue CAGR 3Y17.85%◆ 22.43%14.94%13.17%16.85% +6%
Revenue CAGR 5Y—◆ 27.30%19.03%17.76%21.36%
Net Income CAGR 3Y19.33%9.34%◆ 33.35%18.91%20.53% -6%
Revenue YoY (latest Q)◆ 26.50%20.31%20.56%17.46%19.44% +36%
Net Income YoY (latest Q)-1.09%-15.64%◆ 38.41%2.26%8.34% -113%
Profitability
EBITDA Margin20.84%◆ 26.79%14.94%22.84%21.52% -3%
Net Income Margin12.56%◆ 17.23%7.94%11.66%12.28% +2%
Return on Common Equity15.15%14.33%◆ 21.95%11.08%15.79% -4%
Return on Capital Employed14.78%12.63%◆ 18.20%12.62%14.48% +2%
Return on Assets◆ 10.38%8.89%9.35%7.18%8.47% +23%
Credit & Quality
Total Debt/Equity0.30×0.32×0.57×◆ 0.28×0.39× -23%
Interest Coverage◆ 8.80×7.64×6.44×5.20×6.43× +37%
Scale — latest FY
Revenue / Total Income₹4,410 Cr₹8,373 Cr₹25,229 Cr₹9,128 Cr₹14,243 Cr -69%
Net Income₹554 Cr₹1,442 Cr₹2,003 Cr₹1,064 Cr₹1,503 Cr -63%
Total Assets₹5,905 Cr₹17,231 Cr₹22,197 Cr₹15,966 Cr₹18,465 Cr -68%
EPS₹20.71₹14.83₹135.04₹13.8₹54.56 -62%
Book Value per Share₹147.44₹110.43₹659.26₹131.07₹300.25 -51%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.